HAL (France)
open access
Étude de l’inhibition pharmacologique de RIPK1 dans la cholangite sclérosante primitive
La cholangite sclérosante primitive (CSP) est une maladie cholestatique chronique caractérisée par des sténoses fibro-inflammatoires des canaux biliaires. Aucun traitement efficace n'est disponible pour prévenir la survenue des complications hépatiques de la CSP. La mort des cholangiocytes contribue
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Prospective Database of Infants With Cholestasis#979988
- sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis#1103712
- Secondary Sclerosing Cholangitis in Critically Ill Patients#1114327
- Hidroxicloroquina em doses elevadas provoca alterações nas oscilações cerebrais de baixa frequência em registros eletrocorticográficos de forma não concomitante as alterações na função cardíaca, hepática e renal em ratos wistar#680564
- Becotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase II#909046
Record · ID 1166449
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive